What can be prescribed remotely, and by whom?
Remote prescribing of Schedule 2 stimulants is lawful on two conditions. The prescriber must be entitled to prescribe them, and the clinical assessment behind the prescription must genuinely meet the required standard. Both halves carry weight. On entitlement: doctors can prescribe Schedule 2 controlled drugs. Nurse and pharmacist independent prescribers can prescribe controlled drugs across Schedules 2 to 5 within their competence, with narrow exceptions around treating addiction that do not touch ADHD practice. Under NICE guidance, ADHD diagnosis and treatment initiation sit with appropriately qualified specialist clinicians. In the independent sector, that means consultant psychiatrists and specialist prescribers working within a service registered with the Care Quality Commission (CQC) for treatment.
On assessment: prescribing remotely does not dilute the clinical requirements. This is exactly where the sector's 2026 scrutiny has landed. NICE expects a full assessment before stimulant treatment begins, including cardiovascular history and physical assessment. A remote pathway must build the physical leg in deliberately, not assume video substitutes for it. Some commissioners now mandate face-to-face physical checks for children before treatment; remote prescribers should treat that as the direction of travel, not a local anomaly. The General Medical Council's remote prescribing expectations point the same way. The prescriber must be able to carry out an adequate assessment through the chosen medium — and where they cannot, the medium changes, not the standard. This piece covers what the rules are; our analysis of the 2026 scrutiny covers why they are being watched.
For the pharmacy, the entitlement question becomes a verification duty. Before dispensing any Schedule 2 drug, the pharmacist must take reasonable steps to be satisfied the prescription is genuine and the prescriber is who and what it claims. For ADHD clinic prescriptions, that means checking the prescriber's registration — and for private prescriptions, the specific identifier covered next.
What must the prescription itself contain?
In England, a private prescription for a Schedule 2 stimulant is only dispensable on form FP10PCD. The form must carry the prescriber's six-digit private controlled drug prescriber identification number, alongside the full Schedule 2 prescription requirements. A prescription missing the identifier should not be dispensed. This is the formality remote ADHD services most often get wrong at launch. Each of the clinic's prescribers needs a private CD prescriber identification number, issued through the relevant NHS agency, before the first private prescription is written. Prescriptions go on the designated form (WP10PCD in Wales, PPCD in Scotland). A prescriber without a number gets directed to their NHS England team, not accommodated.
The quantity conventions matter operationally. Good practice limits Schedule 2 prescriptions to 30 days' supply. Most reputable ADHD services follow it, and it shapes the whole service model. A titration patient generates a fresh prescription every cycle, with no shortcut around that, because repeat prescriptions are not permitted on Schedule 2. Every month of treatment is a new prescription, a new dispensing episode and a new set of records. That is why prescription generation, transmission and tracking between clinic and pharmacy needs to run as a designed workflow, not an email thread.
After dispensing, the paper has a destination. FP10PCD forms go to the NHS Business Services Authority monthly, with the FP34PCD submission document, by the fifth day of the following month, on the pharmacy's dedicated private CD account. The pharmacy keeps its own record of the supply for two years. The full mechanics, including the account setup a new pharmacy needs, are set out in our CBPM record-keeping guide. They apply identically here, because the rules are Schedule 2 rules, not medicinal cannabis rules.
How long does an ADHD prescription live, and what dies with it?
Three rules set the operational tempo of an ADHD service. A Schedule 2 prescription is valid for 28 days from the appropriate date. No repeats are permitted. Any owing balance dies at the same 28-day mark. The appropriate date is the signing date or a later start date the prescriber has marked, whichever is later. The 28-day life is unforgiving: a prescription that cannot be dispensed inside it needs reissuing by the prescriber, not stretching by the pharmacy.
The owings rule deserves particular attention here because of the supply environment. ADHD medication shortages have run through 2025 and 2026 across major lines. The tempting response to a stock gap — dispense what you have and owe the rest — collides with the rule that the owed balance cannot be supplied more than 28 days after the appropriate date. An owing created against uncertain wholesale stock is often a promise the supply chain will break. The better pattern is the one we set out for medicinal cannabis dispensing in the CBPM workflow guide: make the shortfall decision on day one and return it to the prescriber, who can switch preparation, adjust or reissue. Do not let the clock decide. The wider shortage playbook, including what pharmacies can and cannot do when a line fails nationally, belongs to our forthcoming ADHD prescriptions handling guide.
Can a pharmacy make an emergency supply of ADHD medication?
No. Emergency supply at the request of a patient does not apply to Schedule 2 controlled drugs. A pharmacy cannot supply methylphenidate, lisdexamfetamine or any other Schedule 2 stimulant to a patient who has run out, whatever the circumstances.
Some patient-facing websites claim pharmacists can supply up to five days of a Schedule 2 ADHD medicine at their discretion. That is simply wrong. The five-day limit being misremembered belongs to a different rule entirely. The only controlled drug exception to the Schedule 2 and 3 emergency supply bar is phenobarbital for epilepsy, which has nothing to do with ADHD practice.
The rule has real consequences for service design, which is why it earns its own section. A patient between prescriptions has exactly one lawful route to medicine: a new prescription from a prescriber. For a remote ADHD service, that makes the clinic's responsiveness the patient's safety net. Build accordingly. The clinic needs a defined urgent-prescription route with a same-working-day standard. Pharmacy SOPs should send out-of-medicine patients to that route immediately, not improvise. And patient communications should set the expectation upstream, at dispensing: reordering starts early, because the pharmacy legally cannot bridge a gap.
"A service that discovers this rule through its first out-of-hours crisis has designed the crisis in."
What does the pharmacy owe the medicine itself?
Safe custody, register discipline and assured delivery. The stimulants are Schedule 2 stock, so they live in the controlled drugs cabinet. They move through the CD register with running balances and prompt entries. They leave the building under arrangements built to reach the right person. None of this is ADHD-specific, and all of it is non-negotiable.
Custody and register. Schedule 2 safe custody applies. The register records every receipt and supply, with balances reconciled on a schedule. Corrections are made by annotation, not deletion, and the register is kept for two years from the last entry. At titration-service volumes, every patient generates monthly dispensing episodes, so the register workload compounds quickly; staff it and own it per session. A controlled drugs register module is scheduled for release on Dataforge PMR at the end of 2026. Until then, the register runs as a disciplined parallel process alongside the PMR.
Collection and delivery. At a counter, Schedule 2 practice means the collector signs and the pharmacy asks for identification. A remote service translates that into the courier leg. That means a tracked, signature-on-delivery service with safe-place and neighbour options disabled. The medicine goes to the patient or a confirmed representative, in plain packaging, with the proof of delivery pulled back into the dispensing record. The patient cohort includes children and young people, so the handover design should also reflect who may lawfully and sensibly receive the medicine. That is a parent or carer question the SOP answers in advance.
| Rule | What it means in a remote ADHD service |
|---|---|
| Schedule 2 classification | Safe custody, CD register, full prescription formalities |
| 28-day validity, no repeats | Fresh prescription every cycle; titration is a prescription-generation workflow |
| 30-day quantity good practice | Monthly dispensing tempo; reorder communications built upstream |
| FP10PCD plus prescriber identifier | Clinic prescribers need private CD numbers before launch; no identifier, no dispensing |
| Monthly NHSBSA submission | FP34PCD by the fifth, on the private CD account |
| Owings die at 28 days | Day-one shortfall decisions, not hopeful part-fills |
| No emergency supply | Clinic urgent-prescription route is the only safety net |
| Delivery assurance | Signature-required, no safe-place, POD filed with the dispensing record |
Where do clinic and pharmacy responsibilities meet?
They meet at verification and at the record, and a remote ADHD service is only as defensible as that interface. The pharmacy verifies the prescriber and records the check: professional registration, private CD identifier, and — for a new clinic relationship — provenance established independently of the prescription itself. The clinic makes sure its prescriptions are formally perfect and its prescribers properly credentialed before volume starts. Both sides hold records that let either reconstruct any supply months later, from assessment through prescription to signed-for delivery.
The interface is also where governance reflects in both directions — a point the 2026 scrutiny has made unavoidable. A pharmacy dispensing for an ADHD clinic is lending its registration to that clinic's clinical model. So the pharmacy's onboarding diligence on a clinic partner should look at the assessment pathway, the physical-check arrangements and the titration records, not just the projected volumes. Equally, a clinic choosing a dispensing partner should demand evidence of the rules in this guide running as workflow. The structural version of that relationship, including when clinic and pharmacy belong under one corporate roof, is the subject of our forthcoming piece on the clinic-plus-pharmacy model. The systems that make the shared record real are covered in the forthcoming IT gap in ADHD and titration services.
Key takeaways
- ADHD stimulants are Schedule 2 controlled drugs. Every rule in this guide flows from that classification, not from anything ADHD-specific.
- Prescriptions live 28 days from the appropriate date and carry no repeats. Owed balances die at the same mark. That sets the monthly tempo the whole service runs on.
- Private prescriptions need form FP10PCD and the prescriber's six-digit private CD identification number — no identifier, no dispensing. Dispensed forms go to the NHSBSA monthly.
- There is no emergency supply of Schedule 2 medicines at patient request. The five-day discretion claim circulating online is wrong. The clinic's urgent-prescription route is the only lawful bridge.
- Remote prescribing is lawful, but the NICE assessment standard — including physical and cardiovascular assessment — travels with it. Commissioners are already mandating face-to-face checks for children.
- The pharmacy owes the stock safe custody, a reconciled register and signature-assured delivery with no safe-place options.
- Clinic and pharmacy meet at verification and records. Each lends the other its regulatory standing, so diligence runs both ways.
Sources and further reading
FAQs
Rules that run as workflow.
Dataforge PMR carries the pharmacy side of the workflow these rules demand: assessments with custom fields tracking titration observations over time, prescriber records and notes in one audit-trailed platform, reminders driving the monthly cycle and review recalls, and dispensing with drug label printing. The controlled drugs register module is scheduled for release at the end of 2026. Our publisher also writes the SOP suites and clinic-pharmacy interface documentation behind services like these. If you are building or auditing an ADHD service, book a 30-minute call.
Book a call